Virupaksha Organics Limited

Oxygenta Pharmaceuticals reported a net loss of ₹175.72 million for FY 2025-26 with accumulated losses of ₹917.51 million resulting in negative equity of ₹426.87 million. Revenue grew 3.4% to ₹1,129.8

Oxygenta Pharmaceutical reported a net loss of ₹175.72 million for FY26 with negative equity of ₹426.87 million despite marginal revenue growth to ₹1,129.82 million. The company convened its 33rd AGM